Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Tyrosine-protein kinase JAK2 is a non-receptor tyrosine kinase that plays a crucial role in cell growth, development, differentiation, and histone modifications. It is a central component of the JAK/STAT signaling pathway, mediating signals from cytokine receptors to regulate gene expression. Dysregulation of JAK2 is implicated in various myeloproliferative disorders.
JAK2 inhibitors block the kinase activity of JAK2, thereby inhibiting the JAK/STAT signaling pathway.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Tyrosine-protein kinase JAK2 (JAK2).